What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Alliance for Clinical Trials in Oncology

Home
United States
Boston, MA
Alliance for Clinical Trials in Oncology

Alliance develops and conducts cancer clinical trials as part of NCI National Clinical Trials Network

11/21/2025

New publication alert! Alliance for Clinical Trials in Oncology researchers led by Matthew Wiedewult, MD, PhD, of Wake Forest University School of Medicine published a study in the Journal of Clinical Oncology showing that two targeted immunotherapy drugs lead to high remission rates and long survival for older patients with a tough-to-treat form of leukemia. https://bit.ly/Alliance-A041703-Cohort1

11/20/2025

For Pancreatic Cancer Awareness month, the Alliance for Clinical Trials in Oncology spotlights Andrew Ko, MD, of the University of California San Francisco, and Erica Tsang, MD, of Princess Margaret Cancer Center. They lead Alliance A022106 (PLATINUM) trial comparing two chemotherapy regimens to treat patients with metastatic pancreatic cancer and the BRCA1/2 or PALB2 mutations. To learn more, visit http://bit.ly/Alliance-A022106.

11/19/2025

Congratulations to Linda Bulone, RN, OCN, of Queens Cancer Center at NYC Health + Hospitals for receiving the Alliance CRP RISE award from the Alliance for Clinical Trials in Oncology for her work advancing cancer research. ://www.linkedin.com/company/nyc-health-and-hospitals-corporation/

11/19/2025

Now Available: Best of Alliance at ASCO 2025 Webinar. Missed the live session? You can now watch the recorded webinar featuring Alliance investigators as they highlight key findings from five leading studies presented at the 2025 ASCO Annual Meeting. Watch the full webinar here https://bit.ly/Alliance-At-ASCO.

11/18/2025

Trial Tuesday! Angela R. Bradbury, MD, of the Perelman School of Medicine at the University of Pennsylvania leads Alliance A232301CD testing if a digital chatbot intervention is as effective as standard remote genetic services in increasing counseling uptake among adolescent and young (AYA) adult cancer patients. To learn more, visit https://bit.ly/AllianceA232301CD.

11/17/2025

From September 1, 2024, through August 31, 2025, Alliance investigators published 51 manuscripts. Of these, 31 papers (66%) appeared in journals with an Impact Factor greater than 5. Notably, six papers were published in high-impact journals with an Impact Factor over 40: two in the New England Journal of Medicine (IF 78.5), one in JAMA (IF 55), one in Nature Medicine (IF 49.2), and two in the Journal of Clinical Oncology (IF 43.4). https://bit.ly/TopJournals

11/14/2025

Radiation oncologist Dean Shumway, MD, of the Mayo Clinic leads Alliance for Clinical Trials in Oncology A012301 (LoTam) comparing low-dose tamoxifen to usual hormonal therapy in treating post-menopausal women with early-stage HER2 . More at https://bit.ly/Alliance-A012301

11/13/2025

Results from Alliance A091802 led by Dan Zanberg, MD, of UPMC Hillman Cancer Center published in the Journal of Clinical Oncology show a new type of immunotherapy called immune checkpoint inhibitors help people with aggressive skin cancer live longer. Read the open access study at https://bit.ly/A091802.

11/12/2025

Lung Cancer Awareness Month: Alliance researcher Jacob Sands, MD, of the Dana-Farber Cancer Institute, leads Alliance A081801 (ALCHEMIST Chemo-IO), a trial testing if adding to after surgery improves survival in non-small cell . To learn more, visit http://bit.ly/Alliance-A081801

11/11/2025

New trial! Bhavana Konda, MD, MPH, of The Ohio State University School of Medicine leads Alliance A092204 exploring if two targeted medications can help slow tumor growth in people with advanced adrenocortical carcinoma, a rare cancer of the adrenal glands. Learn more at https://bit.ly/A092204-Konda.

11/10/2025

The Alliance has launched six new clinical trials recently exploring novel therapies, improved treatment strategies, and innovative approaches to cancer care. From testing new drug combinations for rare and aggressive cancers to evaluating digital health tools that improve access to genetic services, these trials aim to improve outcomes, reduce side effects, and personalize treatment for patients across the lifespan. https://bit.ly/NewTrials2025

11/07/2025

It's a wrap on an exciting three-day meeting! THANK YOU to everyone participating in the 2025 Alliance Fall Group Meeting. Your remarkable efforts continue to advance cancer research. See you next spring - May 13-15!

Address

Alliance For Clinical Trials In Oncology, Office Of The Group Chair 221 Longwood Avenue, Room 108
Boston, MA
02115

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+16177328919

Website

http://www.AllianceforClinicalTrialsinOncology.org/

Alerts

Be the first to know and let us send you an email when Alliance for Clinical Trials in Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.